Organovo Holdings, Inc.

Subscriptions Access My Portal

Filtered by:

2017

3D Bioprinting Solutions (subsidiary of Vivax Bio)

Vivax Bio benchmarks itself against Organovo, which they see as the market leader in 3D bioprinting.

Organovo

Organovo is a 3D bioprinting company focussed on providing liver and kidney tissue testing services to pharmaceutical companies. The company also aims to produce liver tissue patches for therapeutic use.

2016

Poietis

Also developing tissues for drug and cosmetic testing

2015

3-D bioprinted skin tissue

Development of 3-D printed skin tissue for product evaluation and other areas of advanced research.

BioBots (now known as Allevi)

2014

TeVido Biodevices

Organovo also intend to offer 3D bioprinted tissue cultures and intend to cover breast cancer reconstructive surgery.

Organovo

This profile summarizes the activities of the publicly held 3D bioprinter company, Organovo. The company strategy is discussed, and the strengths and weaknesses of its position analysed.